Literature DB >> 8146201

Primacy of liver glucosensors in the sympathetic response to progressive hypoglycemia.

C M Donovan1, M Hamilton-Wessler, J B Halter, R N Bergman.   

Abstract

The impact of hepatic glucose concentration on the sympathetic response to progressive hypoglycemia was examined in chronically cannulated conscious male dogs (n = 6). Graded hypoglycemia was induced via peripheral insulin infusion (30 pmol.kg-1.min-1) with either peripheral (PER) or portal (POR) glucose infusion. Over the 260-min experimental period, arterial glycemia was adjusted from 5.2 +/- 0.1 to 2.5 +/- 0.1 mM in decrements of approximately 0.5 mM every 40 min. Arterial glycemias were not significantly different between PER and POR at any measured level. However, hepatic glycemia was significantly elevated at all times during POR (8.4 +/- 0.8 to 3.4 +/- 0.2 mM) when compared to PER (5.2 +/- 0.2 to 2.5 +/- 0.1 mM). Plasma epinephrine values were significantly greater during PER vs. POR at all arterial glycemias below 4.0 mM. At the lowest level of arterial glycemia studied (2.5 +/- 0.2 mM) the epinephrine response above basal was 3-fold greater for PER (8.7 +/- 1.7 nM) when compared to POR (2.6 +/- 0.6 nM) (P < 0.01). Plasma norepinephrine results were similar for the two protocols, with PER demonstrating a 3-fold greater response above basal when compared to POR at 2.5 mM arterial glycemia (P < 0.05). While the sympathetic response was markedly different between protocols when expressed as a function of arterial glycemia, when expressed as a function of hepatic glycemia this discrepancy was largely eliminated. This latter observation supports the liver as the primary locus for glycemic detection relevant to the sympathoadrenal response when hypoglycemia develops slowly--i.e., over a period of 2-3 h. A comparison of the current findings with our previous observations suggests that the hepatic glucosensors may play a greater role in hypoglycemic counterregulation as the rate of fall in glycemia is less.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8146201      PMCID: PMC43471          DOI: 10.1073/pnas.91.7.2863

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms.

Authors:  N S Schwartz; W E Clutter; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

Review 2.  Overview of counterregulation and its abnormalities in diabetes mellitus and other conditions.

Authors:  J E Gerich; P J Campbell
Journal:  Diabetes Metab Rev       Date:  1988-03

Review 3.  Minireview. The hypothalamus and blood glucose regulation.

Authors:  C A Benzo
Journal:  Life Sci       Date:  1983-05-30       Impact factor: 5.037

4.  Effects of hypothalamic stimulation on gluconeogenesis and glycolysis in rat liver.

Authors:  T Shimazu; S Ogasawara
Journal:  Am J Physiol       Date:  1975-06

5.  Response to deep hypoglycemia does not involve glucoreceptors in carotid perfused tissue.

Authors:  P Cane; C K Haun; J Evered; J H Youn; R N Bergman
Journal:  Am J Physiol       Date:  1988-11

6.  Glucose-sensitive afferent nerve fibers in the liver and their role in food intake and blood glucose regulation.

Authors:  A Niijima
Journal:  J Auton Nerv Syst       Date:  1983-10

7.  Rate of glucose fall does not affect counterregulatory hormone responses to hypoglycemia in normal and diabetic humans.

Authors:  S A Amiel; D C Simonson; W V Tamborlane; R A DeFronzo; R S Sherwin
Journal:  Diabetes       Date:  1987-04       Impact factor: 9.461

8.  Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction.

Authors:  A Mitrakou; C Ryan; T Veneman; M Mokan; T Jenssen; I Kiss; J Durrant; P Cryer; J Gerich
Journal:  Am J Physiol       Date:  1991-01

Review 9.  Central nervous system regulation of liver and adipose tissue metabolism.

Authors:  T Shimazu
Journal:  Diabetologia       Date:  1981-03       Impact factor: 10.122

10.  Comparison of double- and single-isotope enzymatic derivative methods for measuring catecholamines in human plasma.

Authors:  M I Evans; J B Halter; D Porte
Journal:  Clin Chem       Date:  1978-04       Impact factor: 8.327

View more
  25 in total

1.  GLUT4, AMP kinase, but not the insulin receptor, are required for hepatoportal glucose sensor-stimulated muscle glucose utilization.

Authors:  Rémy Burcelin; Valerie Crivelli; Christophe Perrin; Anabela Da Costa; James Mu; Barbara B Kahn; Morris J Birnbaum; C Ronald Kahn; Peter Vollenweider; Bernard Thorens
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

2.  Rate of fall in blood glucose and recurrent hypoglycemia affect glucose dynamics and noradrenergic activation in the ventromedial hypothalamus.

Authors:  Meredith B Barnes; Marcus A Lawson; J Lee Beverly
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-28       Impact factor: 3.619

3.  Regulation of glucose homeostasis in humans with denervated livers.

Authors:  G Perseghin; E Regalia; A Battezzati; S Vergani; A Pulvirenti; I Terruzzi; D Baratti; F Bozzetti; V Mazzaferro; L Luzi
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

Review 4.  Neuroendocrine responses to hypoglycemia.

Authors:  Nolawit Tesfaye; Elizabeth R Seaquist
Journal:  Ann N Y Acad Sci       Date:  2010-10-29       Impact factor: 5.691

Review 5.  Ventromedial hypothalamus glucose-inhibited neurones: A role in glucose and energy homeostasis?

Authors:  Pamela R Hirschberg; Pallabi Sarkar; Suraj B Teegala; Vanessa H Routh
Journal:  J Neuroendocrinol       Date:  2019-08-04       Impact factor: 3.627

Review 6.  Peripheral and central glucose sensing in hypoglycemic detection.

Authors:  Casey M Donovan; Alan G Watts
Journal:  Physiology (Bethesda)       Date:  2014-09

Review 7.  Sweet talk in the brain: glucosensing, neural networks, and hypoglycemic counterregulation.

Authors:  Alan G Watts; Casey M Donovan
Journal:  Front Neuroendocrinol       Date:  2009-10-24       Impact factor: 8.606

8.  Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes.

Authors:  X Fan; Y Ding; S Brown; L Zhou; M Shaw; M C Vella; H Cheng; E C McNay; R S Sherwin; R J McCrimmon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-04-08       Impact factor: 3.619

9.  Essentiality of portal vein receptors in hypoglycemic counterregulation: direct proof via denervation in male canines.

Authors:  Viorica Ionut; Ana Valeria B Castro; Orison O Woolcott; Darko Stefanovski; Malini S Iyer; Josiane L Broussard; Hasmik Mkrtchyan; Miguel Burch; Ram Elazary; Erlinda Kirkman; Richard N Bergman
Journal:  Endocrinology       Date:  2014-01-15       Impact factor: 4.736

Review 10.  Assessing the potential of glucokinase activators in diabetes therapy.

Authors:  Franz M Matschinsky
Journal:  Nat Rev Drug Discov       Date:  2009-04-17       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.